Table 4 Differential blood counts after termination of the cell-based therapy during chemoembolisation with Gemcitabine (Gem), Irinotecan (Irino), Epirubicin (Epi), Oxaliplatin (Oxa)
From: Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report
Date | 08/06 | 09/06 Gem | 11/06 Gem | 01/07 Irino | 03/07 Epi | 04/07 Epi | 07/07 Oxa | 09/07 | 10/07 |
|---|---|---|---|---|---|---|---|---|---|
WBCs, lymphocytes, hemoglobin, thrombocytes after cell-based therapy | |||||||||
[Normal range] healthy donors (n = 6) | |||||||||
Leukocytes (G/l) [≥ 4] | 6 | 7 | 7.6 | 9.9 | 6.4 | 6.3 | 3.4 | 3.3 | 3.0 |
Lymphocytes (%) [15–40%] | (11) | (9) | (6) | (7) | (8) | (7) | (9) | (13) | (13) |
Hemoglobin (g/dl) [≥ 11] | 11.7 | 11.2 | 12.3 | 12.5 | 11.2 | 10.2 | 10.3 | 11.1 | 11.7 |
Thrombocytes (G/l) [≥ 100] | 232 | 239 | 255 | 189 | 357 | 347 | 126 | 115 | 145 |